International Journal of Molecular Sciences
Combination GLP-1RA and Low-Dose IL-2 Modulates Peripheral Immune Activation and Attenuates CNS Inflammatory Transcript Signatures In Vivo
Experiments in animalsInterventions
Papers by Stanley H. Appel
3 results
- AAIC 2025 Abstract
Low‐Dose Interleukin‐2 in Patients with Mild to Moderate Alzheimer's Disease: A Randomized Clinical Trial
Trial in peopleInterventions - AAIC 2025 Abstract
Inflammation clinical trial in mild to moderate Alzheimer's disease: TSPO‐PET results
Trial in peopleInterventions